CNB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Fortress Biotech Inc

Watchlist Manager

Watchlist

Price: 4.131 EUR

Market Cap: €554.9m

F	Fortress Biotech Inc F:CNB	US
	Canfor Corp TSX:CFP	CA
M	Mediobanca Banca di Credito Finanziario SpA F:ME9	IT
C	Colliers International Group Inc F:FSV	CA
N	New Silkroad Culturaltainment Ltd XBER:CP2	HK

Profitability Summary

Fortress Biotech Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

66%

Gross Margin is Increasing

55% > 67%

Negative Operating Margin

-111%

Negative 3Y Average Operating Margin

-172%

Operating Margin is Increasing

-335% > -111%

Negative Net Margin

-3%

Negative 3Y Average Net Margin

-74%

Net Margin is Increasing

-153% > -3%

Negative Free Cash Flow Margin

-104%

Negative 3Y Average Free Cash Flow Margin

-152%

Free Cash Flow Margin is Increasing

-276% > -104%

Negative ROE

-5%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-418%

ROIC is Increasing

-553% > -112%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.